---
title: "FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298841235.md"
description: "The FDA has approved Telix Pharmaceuticals' Pixclara, an F-18 PET imaging drug for glioma scans. This marks the first approved FET-PET agent in the US. The approval covers adults and pediatric patients from one month old, aiding in distinguishing recurrent or progressive glioma from treatment-related changes."
datetime: "2026-09-13T22:32:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298841235.md)
  - [en](https://longbridge.com/en/news/298841235.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298841235.md)
generator: "portal-rs"
---

# FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scans

-   FDA cleared Telix’s Pixclara, an F-18 PET imaging drug for glioma, marking the first approved FET-PET agent in the US. \* Label covers adults, pediatric patients from 1 month old, to help distinguish recurrent or progressive glioma from treatment-related changes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Telix Pharmaceuticals Ltd. published the original content used to generate this news brief on September 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging](https://longbridge.com/en/news/300495723.md)
- [Telix wins FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging study](https://longbridge.com/en/news/300489191.md)
- [Telix Pharmaceuticals Limited (ASX:TLX) To Merge With ITM; $1.65B Upfront, Up To $700M Earnouts](https://longbridge.com/en/news/299574591.md)
- [Telix to acquire ITM in deal worth up to $2.35bn](https://longbridge.com/en/news/299623944.md)
- [Telix Pharmaceuticals announces shareholder meeting](https://longbridge.com/en/news/299579547.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**